Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Medtronic
Dow
Citi
Express Scripts
Cantor Fitzgerald
Federal Trade Commission
Argus Health
US Army

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206214

« Back to Dashboard

NDA 206214 describes LORATADINE, which is a drug marketed by Marksans Pharma, Taro, Apotex Inc, Perrigo, Ranbaxy Labs Ltd, Silarx, Taro Pharm, Teva, Wockhardt Bio Ag, Actavis Labs Fl Inc, Aurobindo Pharma Ltd, Perrigo Pharma Intl, Pfizer, Mylan, Pld Acquisitions Llc, and Sun Pharm Inds Ltd, and is included in twenty-eight NDAs. It is available from one hundred and twenty-six suppliers. Additional details are available on the LORATADINE profile page.

The generic ingredient in LORATADINE is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.
Summary for 206214
Tradename:LORATADINE
Applicant:Marksans Pharma
Ingredient:loratadine
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 206214
Suppliers and Packaging for NDA: 206214
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LORATADINE loratadine CAPSULE;ORAL 206214 ANDA WALGREENS 0363-1686 N 0363-1686-30
LORATADINE loratadine CAPSULE;ORAL 206214 ANDA WALGREENS 0363-1686 N 0363-1686-07

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CAPSULE;ORALStrength10MG
Approval Date:Sep 23, 2016TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Federal Trade Commission
Covington
Moodys
QuintilesIMS
UBS
Boehringer Ingelheim
Deloitte
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.